Family Medicine Doctors in Northampton, PA Accepting Medicare
3 Family Medicine doctors found. Showing 1 - 3
 Uzma Imran, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 602 E 21st St, Northampton, PA 18067 Phone: 610-262-1519 Fax: 610-262-7125 |
Farah Neelam Mirza, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 602 E 21st St Ste 400, Northampton, PA 18067 Phone: 484-526-7275 Fax: 833-820-1011 |
 Dr. Wassim Abosamra, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 602 East 21st Street, Northampton, PA 18067 Phone: 610-262-1519 Fax: 610-262-7125 |
News Archive
Taconic and Oncodesign announce agreement to co-promote and co-develop solutions to advance oncology research
Taconic, a leading provider of life sciences solutions, and Oncodesign(R), an innovative leader in the discovery of novel anti-cancer therapies, announce today that they have entered into an agreement to co-develop and co-promote pre-clinical oncology in vivo solutions for researchers worldwide. The agreement provides researchers with improved access to a large, diverse portfolio of translational models for use in pre-clinical oncology studies, along with supporting scientific services.
KAIST researchers identify principles of gene network for colon tumorigenesis
The principles of the gene network for colon tumorigenesis have been identified by a KAIST research team. The principles will be used to find the molecular target for effective anti-cancer drugs in the future. Further, this research gained attention for using a systems biology approach, which is an integrated research area of IT and BT.
New brain sensor could transform our understanding of Alzheimer's
Scientists at the University of Virginia School of Medicine have developed a tool to monitor communications within the brain in a way never before possible, and it has already offered an explanation for why Alzheimer's drugs have limited effectiveness and why patients get much worse after going off of them.
DermTech completes enrollment in clinical study to assess DNA damage and reversal
DermTech, Inc., the global leader in non-invasive molecular dermatology, announced today it has completed enrollment in a clinical study to assess DNA damage induced by an excimer laser and evaluate the potential of topical agents T4 endonuclease and photolyase to reduce DNA damage induced as measured through gene expression analysis.
› Verified 5 days ago
Internal Medicine
Family Medicine
Physical Medicine & Rehabilitation